The search found 4 results in 0.281 seconds.
Objective: To describe why, when and to whom general practitioners refer women with symptoms possibly attributable to cervical, endometrial or ovarian cancers, and to identify patient and GP factors that predict referral to either a gynaecologist or a gynaecological oncologist.
This article concludes that the incidence and multiplicity of keratinocyte cancer in Australia are very high, causing a large disease burden that has not previously been quantified.
Starting cervical cancer screening at age 25 is safe. The findings support the Australian government’s renewed cervical screening program (set to come into effect in May 2017), which recommends that women should start screening for cervical cancer at age 25, not age 18-20.
We used an Australian population-based cancer database to estimate the total number of cancers to be diagnosed in 2025, by applying published age- and sex-specific population projections to current cancer incidence rates, and multiplying the projected numbers of cancers by estimates of population-attributable fractions. Projected...